Focused Shockwave Treatment for Greater Trochanteric Pain Syndrome: A Multicenter, Randomized, Controlled Clinical Trial.

Greater trochanteric pain syndrome, a common cause of pain on the outer hip, has no agreed-upon best treatment, which makes trials comparing options worth attention. This trial compared electromagnetic focused shockwave treatment plus an exercise program against a sham shockwave treatment plus the same exercises, in 103 patients followed for six months. Pain scores dropped in both groups, but the group receiving real shockwave treatment showed a substantially larger reduction at the two-month mark, and this advantage was reflected across most other measures of hip function and quality of life at nearly every follow-up point. What makes this interesting is that the comparison group also exercised and also improved, so the added benefit appears tied to the shockwave treatment itself rather than exercise alone.

No complications were reported. Still, this is a single trial, and while it used a sham comparator, longer-term outcomes beyond six months and how this compares with other established treatments remain unaddressed.

If you've dealt with pain on the outer part of your hip that doctors call greater trochanteric pain syndrome, you know how frustrating it can be that there's no clear best treatment. This study looked at whether adding a real electromagnetic shockwave treatment to a hip exercise program worked better than doing the exercises alongside a fake, low-energy version of the same treatment. Both groups improved over time, but people who received the real shockwave treatment reported notably less pain by two months, and this held true for other measures like hip function and daily activity through six months of follow-up.

No safety problems were reported in either group. This is encouraging news for a condition with limited treatment consensus, but it comes from one trial, and questions remain about how these results compare with other treatment approaches or how durable the benefit is beyond six months. It shouldn't be read as settling the question of what treatment works best for everyone with this condition.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This multicenter randomized controlled trial (n=103) compared electromagnetic focused extracorporeal shockwave treatment (F-ESWT, 0.20 mJ/mm) plus a standardized exercise protocol against sham F-ESWT (0.01 mJ/mm) plus the identical exercise protocol, in patients with chronic greater trochanteric pain syndrome. The primary outcome, VAS pain score at 2 months, fell from a baseline of 6.3 in both arms to 2.0 in the treatment group versus 4.7 in the sham arm, a statistically significant between-group difference (p<0.001). Secondary outcomes, including the Harris hip score, Lower Extremity Functional Scale, EQ-5D, and Roles and Maudsley score, favored the F-ESWT group at nearly all follow-up points through 6 months, with the exception of the Lower Extremity Functional Scale at 1 month, which showed no statistically significant difference (p=0.25).

A reported success rate of 86.8% at 2 months was maintained to the end of follow-up, though the abstract does not define this metric's exact criteria in detail here. No complications were reported in either arm. As a Level I therapeutic study with sham control and standardized co-intervention, this design strengthens confidence that the shockwave component itself contributed to the observed benefit, though replication and longer follow-up would clarify durability and comparative effectiveness against other treatments.